Profound Medical Corp. (PROF) stock forecast and price target
Price $7.42 · data as of November 13, 2026
12-month price target
Average target$11.14
Upside / downside+50.1%
Analysts5
ConsensusStrong buy
Low $10.00Average $11.14High $12.00
Gold marker: average target · white marker: today’s price ($7.42)
Analyst ratings
Strong buy 0Buy 5Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.93 | +34.2% | $36M |
| Next fiscal year ends December 31, 2027 | $-0.61 | +34.0% | $61M |
| Next quarter ends December 31, 2026 | $-0.26 | +4.6% | $11M |
| Quarter after ends March 31, 2027 | $-0.22 | −14.0% | $12M |
Consensus of the analysts covering Profound Medical, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.
Frequently asked questions
What is the Profound Medical stock price target?
The average 12-month target from 5 analysts is $11.14, 50.1% above the current price of $7.42 Targets range from $10.00 to $12.00.
Is Profound Medical a buy according to analysts?
The consensus rating is “Strong buy” (5 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Profound Medical expected to earn?
Analysts expect EPS of $-0.93 for the fiscal year ending December 31, 2026 and $-0.61 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.